Literature DB >> 8446782

Infection of dendritic cells with HIV1: virus load regulates stimulation and suppression of T-cell activity.

S C Knight1, S E Macatonia, S Patterson.   

Abstract

Patients with HIV infection show two major types of immunological effects. The first is hyperactivity of both T and B lymphocytes which may be in response to HIV antigens themselves, and the second is a loss in T-cell activity in response to other antigens. Dendritic cells (DC) show a higher rate of infection with HIV than other peripheral blood cells in vitro and in vivo. The effects of HIV infection of DC in vitro on their stimulating capacity for T cells were, therefore, examined. We compared the development of the capacity to stimulate primary proliferative responses to virus in autologous lymphocytes with their potency in stimulating allogeneic cells in the mixed leukocyte reaction (MLR). Small numbers of uninfected DC caused little or no stimulation of autologous lymphocytes, but stimulated high MLR. The level of HIV infection in in vitro infected DC preparations was dependent on the time of infection and the titre of the input virus. DC exposed to low doses of HIV (e.g., 10(3) TCID/10(6) cells) for up to 4 days or to a higher dose (e.g. 10(5) TCID/10(6) cells) for 1 day caused significant primary proliferation in autologous T cells and, under these conditions, capacity to stimulate allogeneic MLR remained intact. However, DC exposed to increasing doses of HIV or infected for a longer period showed reduced capacity to stimulate allogeneic lymphocytes and then a loss of stimulation of autologous cells. This provides evidence suggesting that both stimulatory and inhibitory effects of HIV infection can be produced through infection of DC.

Entities:  

Mesh:

Year:  1993        PMID: 8446782     DOI: 10.1016/s0923-2516(06)80015-4

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  8 in total

Review 1.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

2.  Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.

Authors:  M Shi; S Qian; W-W Chen; H Zhang; B Zhang; Z-R Tang; Z Zhang; F-S Wang
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 3.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production.

Authors:  Mohamed M S Farag; Reda A Suef; Ghada M Al-Toukhy; Mohamed A Selim; Mostafa A Elbahnasawy; Nahla El Sharkawy; Sameera Ezzat; Nashwa Shebl; Mohamed T M Mansour
Journal:  Infect Drug Resist       Date:  2020-08-05       Impact factor: 4.003

5.  MHC class I and II peptide homology regulates the cellular immune response.

Authors:  Matthew M Halpert; Vanaja Konduri; Dan Liang; Jonathan Vazquez-Perez; Colby J Hofferek; Scott A Weldon; Yunyu Baig; Indira Vedula; Jonathan M Levitt; William K Decker
Journal:  FASEB J       Date:  2020-04-16       Impact factor: 5.191

6.  Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.

Authors:  Susanne Beckebaum; Vito R Cicinnati; Xia Zhang; Stanislav Ferencik; Andrea Frilling; Hans Grosse-Wilde; Christoph Erich Broelsch; Guido Gerken
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

Review 7.  Utilizing the FIV model to understand dendritic cell dysfunction and the potential role of dendritic cell immunization in HIV infection.

Authors:  Tracy L Lehman; Kevin P O'Halloran; Edward A Hoover; Paul R Avery
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

8.  Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans.

Authors:  Xue-Zhang Duan; Min Wang; Han-Wei Li; Hui Zhuang; Dongping Xu; Fu-Sheng Wang
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.